α-lactalbumin vaccine
CASE6119
Phase 1 mab active
Quick answer
α-lactalbumin vaccine for Pathologic Stage IIA-IIIC Triple-Negative Breast Cancer is a Phase 1 program (mab) at Anixa Biosciences Inc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Anixa Biosciences Inc
- Indication
- Pathologic Stage IIA-IIIC Triple-Negative Breast Cancer
- Phase
- Phase 1
- Modality
- mab
- Status
- active